Search Results - "Lana McMillan"

Quantitative Mass Spectrometry by SILAC in Haloferax volcanii by Couto-Rodriguez, Ricardo L, Gal, Daniel, McMillan, Lana J, Koh, Jin, Chen, Sixue, Maupin-Furlow, Julie A

“…The development of mass spectrometry (MS)-based proteomics methods has been critical in providing new insight about cellular processes and adaptations in all…”
Get more information

Multiplex quantitative SILAC for analysis of archaeal proteomes: a case study of oxidative stress responses by McMillan, Lana J., Hwang, Sungmin, Farah, Rawan E., Koh, Jin, Chen, Sixue, Maupin‐Furlow, Julie A.

“…Summary Stable isotope labelling of amino acids in cell culture (SILAC) is a quantitative proteomic method that can illuminate new pathways used by cells to…”
Get full text

Archaeal Inorganic Pyrophosphatase Displays Robust Activity under High-Salt Conditions and in Organic Solvents by McMillan, Lana J, Hepowit, Nathaniel L, Maupin-Furlow, Julie A

“…Soluble inorganic pyrophosphatases (PPAs) that hydrolyze inorganic pyrophosphate (PPi) to orthophosphate (Pi) are commonly used to accelerate and detect…”
Get full text

GlpR is a direct transcriptional repressor of fructose metabolic genes in Haloferax volcanii by Martin, Jonathan H, Rawls, Katie Sherwood, Chan, Jou Chin, Hwang, Sungmin, Martinez-Pastor, Mar, McMillan, Lana J, Prunetti, Laurence, Schmid, Amy K, Maupin-Furlow, Julie A

“…DeoR-type helix-turn-helix (HTH) domain proteins are transcriptional regulators of sugar and nucleoside metabolism in diverse bacteria and occur in select…”
Get full text

Molecular Factors of Hypochlorite Tolerance in the Hypersaline Archaeon Haloferax volcanii by Gomez, Miguel, Leung, Whinkie, Dantuluri, Swathi, Pillai, Alexander, Gani, Zyan, Hwang, Sungmin, McMillan, Lana J, Kiljunen, Saija, Savilahti, Harri, Maupin-Furlow, Julie A

“…Halophilic archaea thrive in hypersaline conditions associated with desiccation, ultraviolet (UV) irradiation and redox active compounds, and thus are…”
Get full text

429 Implementing a practical induction programme in a tertiary teaching hospital by Mcmillan, Lana, McKie, Allison

“…ObjectivesOur aim was to gather feedback about the original induction programme and make adjustments to deliver relevant content to trainees. New sessions were…”
Get full text

In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials by Selle, Kurt, Fletcher, Joshua R, Tuson, Hannah, Schmitt, Daniel S, McMillan, Lana, Vridhambal, Gowrinarayani S, Rivera, Alissa J, Montgomery, Stephanie A, Fortier, Louis-Charles, Barrangou, Rodolphe, Theriot, Casey M, Ousterout, David G

“…is an important nosocomial pathogen that causes approximately 500,000 cases of infection (CDI) and 29,000 deaths annually in the United States. Antibiotic use…”
Get full text

Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial by Kim, Paul, Sanchez, Ana M, Penke, Taylor J R, Tuson, Hannah H, Kime, James C, McKee, Robert W, Slone, William L, Conley, Nicholas R, McMillan, Lana J, Prybol, Cameron J, Garofolo, Paul M

“…The rate of antibiotic resistance continues to grow, outpacing small-molecule-drug development efforts. Novel therapies are needed to combat this growing…”
Get full text

Archaeal Inorganic Pyrophosphatase Displays Robust Activity under High-Salt Conditions and in Organic Solvents by McMillan, Lana J., Hepowit, Nathaniel L., Maupin-Furlow, Julie A.

“…Soluble inorganic pyrophosphatases (PPAs) that hydrolyze inorganic pyrophosphate (PPi) to orthophosphate (Pi) are commonly used to accelerate and detect…”
Get full text

Multiplex quantitative SILAC for analysis of archaeal proteomes: a case study of oxidative stress responses: Multiplex SILAC for archaeal proteomics by McMillan, Lana J., Hwang, Sungmin, Farah, Rawan E., Koh, Jin, Chen, Sixue, Maupin-Furlow, Julie A.

“…Not provided…”
Get full text

italic toggle="yes">In Vivo /italic> Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials by Kurt Selle, Joshua R. Fletcher, Hannah Tuson, Daniel S. Schmitt, Lana McMillan, Gowrinarayani S. Vridhambal, Alissa J. Rivera, Stephanie A. Montgomery, Louis-Charles Fortier, Rodolphe Barrangou, Casey M. Theriot, David G. Ousterout

“…ABSTRACT Clostridioides difficile is an important nosocomial pathogen that causes approximately 500,000 cases of C. difficile infection (CDI) and 29,000 deaths…”
Get full text